Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

DelMar Pharmaceuticals Company Profile (NASDAQ:DMPI)

Consensus Ratings for DelMar Pharmaceuticals (NASDAQ:DMPI) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $6.25 (681.25% upside)

Analysts' Ratings History for DelMar Pharmaceuticals (NASDAQ:DMPI)
Show:
DateFirmActionRatingPrice TargetDetailsShare
6/3/2014ZacksReiterated RatingOutperform -> Outperform$4.50ViewTweet This Rating  Share This Rating on StockTwits
4/3/2014Maxim GroupInitiated CoverageBuy$8.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 8/1/2012 forward)